251 related articles for article (PubMed ID: 22275352)
1. Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid.
Isobe Y; Arita M; Matsueda S; Iwamoto R; Fujihara T; Nakanishi H; Taguchi R; Masuda K; Sasaki K; Urabe D; Inoue M; Arai H
J Biol Chem; 2012 Mar; 287(13):10525-10534. PubMed ID: 22275352
[TBL] [Abstract][Full Text] [Related]
2. Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3.
Isobe Y; Arita M; Iwamoto R; Urabe D; Todoroki H; Masuda K; Inoue M; Arai H
J Biochem; 2013 Apr; 153(4):355-60. PubMed ID: 23293324
[TBL] [Abstract][Full Text] [Related]
3. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.
Serhan CN; Yang R; Martinod K; Kasuga K; Pillai PS; Porter TF; Oh SF; Spite M
J Exp Med; 2009 Jan; 206(1):15-23. PubMed ID: 19103881
[TBL] [Abstract][Full Text] [Related]
4. Identification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite.
Yokokura Y; Isobe Y; Matsueda S; Iwamoto R; Goto T; Yoshioka T; Urabe D; Inoue M; Arai H; Arita M
J Biochem; 2014 Dec; 156(6):315-21. PubMed ID: 25012818
[TBL] [Abstract][Full Text] [Related]
5. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis.
Tjonahen E; Oh SF; Siegelman J; Elangovan S; Percarpio KB; Hong S; Arita M; Serhan CN
Chem Biol; 2006 Nov; 13(11):1193-202. PubMed ID: 17114001
[TBL] [Abstract][Full Text] [Related]
6. Platelet-neutrophil interactions. 12S,20- and 5S,12S-dihydroxyeicosapentaenoic acids: two novel neutrophil metabolites from platelet-derived 12S-hydroxyeicosapentaenoic acid.
von Schacky C; Marcus AJ; Safier LB; Ullman HL; Islam N; Broekman MJ; Fischer S
J Lipid Res; 1990 May; 31(5):801-10. PubMed ID: 2116491
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid is converted via ω-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid.
Kubota T; Arita M; Isobe Y; Iwamoto R; Goto T; Yoshioka T; Urabe D; Inoue M; Arai H
FASEB J; 2014 Feb; 28(2):586-93. PubMed ID: 24128889
[TBL] [Abstract][Full Text] [Related]
8. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.
Oh SF; Pillai PS; Recchiuti A; Yang R; Serhan CN
J Clin Invest; 2011 Feb; 121(2):569-81. PubMed ID: 21206090
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis and bioactivity of 18(R)-hydroxyeicosapentaenoic acid.
Krishnamurthy VR; Dougherty A; Haller CA; Chaikof EL
J Org Chem; 2011 Jul; 76(13):5433-7. PubMed ID: 21598971
[TBL] [Abstract][Full Text] [Related]
10. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice.
Yamada T; Tani Y; Nakanishi H; Taguchi R; Arita M; Arai H
FASEB J; 2011 Feb; 25(2):561-8. PubMed ID: 20959515
[TBL] [Abstract][Full Text] [Related]
11. Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators.
Oh SF; Vickery TW; Serhan CN
Biochim Biophys Acta; 2011 Nov; 1811(11):737-47. PubMed ID: 21712098
[TBL] [Abstract][Full Text] [Related]
12. Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice.
Tani Y; Isobe Y; Imoto Y; Segi-Nishida E; Sugimoto Y; Arai H; Arita M
FASEB J; 2014 Sep; 28(9):4036-43. PubMed ID: 24891522
[TBL] [Abstract][Full Text] [Related]
13. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
Mas E; Croft KD; Zahra P; Barden A; Mori TA
Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
[TBL] [Abstract][Full Text] [Related]
14. Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase.
Dobson EP; Barrow CJ; Kralovec JA; Adcock JL
J Lipid Res; 2013 May; 54(5):1439-47. PubMed ID: 23471029
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 12/15-lipoxygenase metabolism of EPA and DHA with special attention to authentication of docosatrienes.
Jin J; Boeglin WE; Brash AR
J Lipid Res; 2021; 62():100088. PubMed ID: 34022182
[TBL] [Abstract][Full Text] [Related]
16. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.
Serhan CN; Arita M; Hong S; Gotlinger K
Lipids; 2004 Nov; 39(11):1125-32. PubMed ID: 15726828
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.
Hung ND; Kim MR; Sok DE
Br J Pharmacol; 2011 Mar; 162(5):1119-35. PubMed ID: 21091644
[TBL] [Abstract][Full Text] [Related]
18. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
Serhan CN; Gotlinger K; Hong S; Arita M
Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis.
Hung ND; Kim MR; Sok DE
Inflammation; 2011 Jun; 34(3):147-60. PubMed ID: 20490641
[TBL] [Abstract][Full Text] [Related]
20. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
Barden AE; Shinde S; Burke V; Puddey IB; Beilin LJ; Irish AB; Watts GF; Mori TA
Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
